Debt-to-Equity Ratio

The debt-to-equity ratio measures how much of a company’s operations are funded by debt compared to its own shareholders’ equity.

MRNA’s current ratio of 0.08x means it has very little debt relative to equity, indicating a conservative capital structure. This is far below the sector median of 0.73x, placing MRNA in the 14th percentile among its peers — meaning it uses less debt than most companies in its industry. The year-over-year change is not available, but the quarter-over-quarter change shows a decline of 55.6% from the prior quarter’s 0.18x to the current 0.08x, reflecting a sharp further reduction in leverage. The combination of an already low level and a continuing downward trend implies minimal financial risk from debt, which could be a stabilizing factor for investors. This metric directly contradicts the overall CAUTIOUS verdict, as low debt typically reduces bankruptcy risk and suggests the company is not overextended — though other factors likely drive the cautious outlook.

Frequently Asked Questions

Closest Sector Peers